https://www.selleckchem.com/products/sant-1.html
In psoriatic arthritis (PsA), the treatment objective is remission (REM) or low disease activity (LDA), but patients' perception of REM is poorly studied. This analysis aimed to identify factors associated with patient-defined REM. This analysis uses ReFlaP data, an international PsA study, with REM defined as "At this time, is your psoriatic arthritis in remission, if this means you feel your disease is as good as gone?". Variables associated with first patient-defined REM and secondly LDA were identified using multivariable logistic re
Gefällt mir
Kommentar
Teilen
